PAD2 immunization induces ACPA in wild type and HLA‐DR4 humanized mice - Inserm - Institut national de la santé et de la recherche médicale Access content directly
Journal Articles European Journal of Immunology Year : 2022

PAD2 immunization induces ACPA in wild type and HLA‐DR4 humanized mice

Abstract

Rheumatoid arthritis (RA) is associated with HLA-DRB1 alleles expressing the "shared epitope". RA is usually preceded by the emergence of anti-citrullinated protein autoantibodies (ACPAs). ACPAs recognize citrulline residues on numerous proteins. Conversion of arginine into citrulline is performed by enzymes called peptidyl arginine deiminases (PADs). We have previously demonstrated that C3H mice immunized with PADs can produce ACPAs by a hapten-carrier mechanism. Here, we address the influence of HLA-DR alleles in this model in mice expressing RA-associated HLA-DRB1*04:01 (KO/KI*04:01) or HLA-DRB1*04:04 (KO/KI*04:04) or non RA-associated HLA-DRB1*04:02 (KO/KI*04:02) after murine PAD2 (mPAD2) immunization. Immunization with mPAD2 triggers production of ACPAs in wild type (WT) and HLA-DR4 C57BL/6 mice. Both I-Ab and HLA-DR are involved in the activation of mPAD2 specific T lymphocytes. Among HLA-DR4 mice, mice expressing RA-associated HLA-DRB1*04:01 are the best responders to mPAD2 and the best anti-citrullinated peptide antibody producers. This article is protected by copyright. All rights reserved.
Embargoed file
Embargoed file
Ne sera jamais visible

Dates and versions

inserm-03702261 , version 1 (23-06-2022)

Identifiers

Cite

Marie F Hemon, Nathalie C Lambert, Jean Roudier, Isabelle Auger. PAD2 immunization induces ACPA in wild type and HLA‐DR4 humanized mice. European Journal of Immunology, 2022, Online ahead of print. ⟨10.1002/eji.202249889⟩. ⟨inserm-03702261⟩

Collections

INSERM UNIV-AMU
20 View
105 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More